Cleveland Clinic icon
Consult QD logo

Tag: multiple sclerosis (MS)

22-NEU-2902059_multiple-sclerosis_650x450
June 22, 2022/Neurosciences/Multiple Sclerosis

Phase 2 Data Show Vidofludimus Calcium Suppresses MRI Lesions in Relapsing MS With Good Tolerability

Selective DHODH inhibitor designed as a better-tolerated alternative to teriflunomide

22-NEU-2826663_multiple-sclerosis-650×450
April 1, 2022/Basic & Translational Science

Pair of NIH Grants to Probe Multiple Sclerosis Pathogenesis on Two Fronts

Assessing the role of circadian disruption, characterizing patterns of thalamic atrophy

22-NEU-2678473-CQD-Hero-650×450
March 22, 2022/Neurosciences/PM&R

Medical Management of Gait Impairment in Multiple Sclerosis: Time to Mind the Data Gaps

More evidence needed on pharmacologic therapy alone and combined with gait training

22-NEU-2798010-CQD-Hero-650×450
March 17, 2022/Neurosciences/Multiple Sclerosis

Three Standout Investigations at ACTRIMS 2022

Research avenues to keep an eye on in MS and NMOSD diagnostics and therapeutics

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-NEU-2651159_Epstein-Barr-virus_650x450
February 7, 2022/Neurosciences/Multiple Sclerosis

Epstein-Barr Virus and Development of MS: Required, but Not Sufficient

Be careful not to overinterpret a recent important study

21-NEU-2489213-breakhrough-infection-650×450
November 12, 2021/COVID-19

Breakthrough COVID-19 in Patients With Multiple Sclerosis: Snapshot From One Data Registry

Unlikely to be severe, infections are associated with anti-CD20 therapies and fingolimod

21-NEU-2477458_teleneurology-cartoon_650x450
November 2, 2021/Health Information Technology

Virtual Visits Match In-Person Visits for Multiple Sclerosis Care, Longitudinal Study Shows

Findings support a role for teleneurology in MS management

21-NEU-2474109_mesenchymal-stem-cells_650x450
October 15, 2021/Neurosciences/Multiple Sclerosis

Intrathecally Delivered Enhanced Stem Cells Show Promise in Progressive MS

Phase 2 clinical study supports safety and efficacy of MSC-NTFs

21-NEU-2259158 MS-in-Black-Americans_650x450
August 9, 2021/Neurosciences/Multiple Sclerosis

Black Americans Suffer Greater Multiple Sclerosis Disease Burden Than Whites

Database study reveals racial differences across clinical and imaging domains

21-NEU-2245408_mri-in-MS_650x450
July 8, 2021/Basic & Translational Science

How Well Do Current MRI Modalities Measure Cortical Lesion Load in Multiple Sclerosis?

Shortcomings in specificity show influence of cortical changes beyond demyelination

BackPage 3 of 10Next

Advertisement

Ad